Hyzaar Asia HEAALTH (0954A-950)

Phase 3 Completed 437 enrolled Merck Sharp & Dohme LLC

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objective of the study is to estimate the percentage of patients who reach blood pressure goal after 8 weeks of treatment with losartan/HCTZ combination.

Timeline

Start: 2006-06-01
Primary completion: 2007-04-01
Completion: 2007-04-01

Publications

Kim KS, Fan WH, Kim YD, Zhu W, Ngau YY, Tong P, Kim BS, Santos M, Lin WH, Buranakitjaroen P, Massaad R, Smith RD; Asia HEAALTH Study Investigators. Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy. Hypertens Res. 2009 Jun;32(6):520-6. doi: 10.1038/hr.2009.42. Epub 2009 Apr 24.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydrochlorothiazide	Unknown	12.5 mg	Oral
Subject	Hydrochlorothiazide	Unknown	25 mg	Oral
Subject	Losartan	Other / unclassified	50 mg	Oral
Subject	Losartan	Other / unclassified	100 mg	Oral

Hyzaar Asia HEAALTH (0954A-950)

Summary

Timeline

Publications

Drugs

Indications